Skip to main content

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Aluminum Corp of China

(ACH)

downgraded at Deutsche to Hold from Buy at Deutsche Bank.

Air Methods

(AIRM)

initiated at RBC with a Sector perform rating and $34 price target at RBC Capital.

Amkor Technologies

(AMKR)

upgraded at Deutsche to Buy from Hold. Price target lifted to $8 from $7.50.

American Public Education

(APEI)

downgraded at Barrington Research to Market Perform from Outperform. Valuation call.

Scroll to Continue

TheStreet Recommends

Biomed Realty Trust

(BMR)

upgraded at Wells Fargo to Outperform from Market Perform.

Celgene

(CELG)

upgraded at Cowen to Neutral from Underperform.

Covance

(CVD)

upgraded at Wells Fargo to Outperform from Market Perform.

Callaway Golf

(ELY)

downgraded at JMP Securities to Market Perform from Outperform.

Emergency Medical Services

( EMS) initiated at RBC with an Outperform rating and $66 price target.

Finish Line

(FINL)

upgraded at Citi to Buy from Hold on accelerating sales and earnings. Price target increased to $20 from $18. Estimates raised through 2012.

Home Depot

(HD)

price target cut at FBR Capital to $36 from $40 on expected "OK" 2Q10 sales. Maintain Outperform rating.

Jazz Pharmaceuticals

(JAZZ)

upgraded at Barclays to Overweight from Equal Weight on valuation. Price target raised to $15 from $12.

Lincare

( LNCR) downgraded at Susquehanna to Neutral from Positive.

PAA Natural Gas Storage

(PNG)

initiated at Barclays with an Overweight rating and $27 price target. Visible organic growth should drive 8% distribution growth over next 3 years.

Gibraltar Industries

(ROCK)

upgraded at Jefferies to Buy from Hold. Price target raised to $16 from $13.

Rosetta Resources

(ROSE)

downgraded at Suntrust to Neutral from Buy.

Rural/Metro

( RURL) initiated at RBC with an Outperform rating and $9 price target.

SuccessFactors

( SFSF) initiated at RBC with an Outperform rating and $27 price target.

T. Rowe Price

(TROW)

upgraded at Wells Fargo to Outperform from Market Perform.

Vivus

undefined

downgraded at Lazard to Hold from Buy.

STOCK COMMENTS / EPS CHANGES

Cytec

(CYT)

estimates raised at Credit Suisse. CYT 2010, 2011 and 2012 EPS estimates lifted to $2.68, $3.48, and $4.39, respectively. CYT offers significant growth in 2010 and beyond. Maintain Outperform rating and $58 price target.

Energy Recovery

(ERII)

price target cut at Citi to $4 from $7.50 on lower guidance. Maintain Hold rating.

Tenet Healthcare

(THC)

estimates raised at Goldman. THC 2010 and 2011 EPS estimates lifted to $0.39 and $0.42, respectively, on favorable trends. Maintain Neutral rating and $5.50 price target.

Tenet Healthcare

(THC)

estimates higher at Barclays. THC 2010 and 2011 EPS estimates boosted to $0.37 and $0.39, respectively, on cost improvements. Reiterate Overweight rating and $8 price target.

This article was written by a staff member of TheStreet.com.